Last edition
News about "Syngene International "
With this new capability, Syngene will offer fully integrated, end-to-end services for antibody-drug conjugates (ADCs) – from discovery through to GMP manufacturing – placing it among a handful of CDMOs with full-service capabilities.
Syngene International | 24/10/2025 | By Darshana
Syngene International Invests in Peptide Laboratory and Advanced Automation
Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.
Syngene International | 16/10/2025 | By Dineshwori
Syngene Rolls Out New Platform for Enhanced Protein Production
Syngene International Ltd. has introduced its new protein production platform.
Syngene International | 05/06/2024 | By Aishwarya | 594
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy